RPLP2 and non-Hodgkin lymphoma: Considering the inhibitory effect of Destruxin b on a variety of cancers, including NHL [26,27,28,29], we further utilized the molecular protein interaction prediction model to predict the possibility of binding Destruxin b to RPLP2.